VOLITIONRX LTD — Director's Dealing 2017

Mar 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-03-17

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-17	Warrant (Right to Buy)	$2.6	S	5000	Disposed	2017-05-10	Common Stock (5000)	Indirect

Footnotes

F1: The Warrant is held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable upon the exercise of the Warrant. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issuable upon the exercise of the Warrant, except to the extent of his pecuniary interest.